Formulation and Evaluation of Herbal Gel Containing Kigelia africana(lam.) Benth., Fruits Extract
DOI:
https://doi.org/10.53555/nnas.v2i4.680Keywords:
Kigelia africana(Lam.), Benth, aqueous extract, Carbapol 940, herbal Gel, skin irritation.Abstract
Herbal medicine has become an item of global importance both medicinal and economical. Although usage of these herbal medicines has increased, their quality, safety and efficiency are serious concerns in industrialized and developing countries. The present research has been undertaken with the aim to formulate and evaluate the herbal gel containing Kigelia africana(Lam.) Benth., fruits extract. The gel formulation was designed by using Carbapol 940, Kigelia africana(Lam.) Benth., fruits extract, propylene glycol, methyl paraben, propyl paraben and required amount of distilled water. The skin pH (6.8-7.1) was maintained by drop wise addition of Triethanolamine. The physicochemical Parameters of formulations (pH, Spreadibility, Stability etc.) were determined. Stability studies have carried out as per ICH guidelines for 3 months at different temperatures and humidity. The results showed that formulation ontaining Kigelia africana(Lam.) Benth., fruits extract Show better stability. Further formulations have studied for skin irritation on animal model (Rat) and result showed that there was no skin irritation to animals.
References
Dubey NK, Kumar R, Tripati P. Global promation of herbal medicines: India’s Opportunity. Curr Med 2004; 86: 37-41.
Grace OM, Light ME, Lindsey KI, Mulholland DA, van Staden J, Jager AK, Antibacterial activity and isolation of active compounds from fruit of the traditional African medicinal tree Kigelia africana, South Afr J Bot. 2002;68(1);220-222.
cragg GM and NEWMAN DJ, medicinal for the millennia, An n NY Acad, sci 2001, 953, 3-25.
Tzu L, Cheng W, Chia C, Shu H, Wang S. Luteolin Inhibits the Release of Glutamate in Rat Cerebrocortical Nerve Terminals. J Agric Food Chem 2011; 59 (15), 8458-66.
Guterres SS, Alves MP, Pohlamnn AR. Polymeric nanoparticles, nanospheres and nanocapsules for cutaneous applications. Drug Target Insights. 2007; 2147-157.
Allen L, V Jr. The Basics of Compounding. Int J Pharm Compd. 1999; 3: 385-389.
Weller PJ. Handbook of Pharmaceutical Excipients. American Pharmaceutical Association., Washington DC, 2003,p. 521-523.
Panchangula R, Salve PS, Thomas NS, Jain AK, Ramarao P. Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm. 2001; 219: 95-105.
Sudipta D, Pallab KH, Goutam P. International Journal of PharmTech Research. 2011; 3:140-143.
Carl AB, Edward RA.Text book of clinical chemistry and molecular diagnostics.4th rev. ed. W.B Saunders Philadelphia; 2001.
Patel RP, Kamani R. Formulation optimization and evaluation of mometazone furoatecream. J Pharm Res. 2002; 2: 1565-1569.
Panigrahi L, Ghosal SK, Pattnaik S, Maharana L, Barik BB. Effect of permeation enhancers on the Release and permeation kinetics of Lincomycin Hydrochloride gel formulations through Mouse skin. Indian J Pharm Sci 2006; 205-211
Pandit JK, Bharathi D, Srinatha A, Ridhurkar DN, Singh S. Long acting ophthalmicformulation of indomethacin: Evaluation of alginate gel systems. Ind J Pharm Sci. 2007; 69: 37-40.
Das K, Dang R, Machale UM. The Pharma Review. 2010; 8:112.
Prakash RP, Rao R. J.pharmaceutical and clinical research. 2010; 3: 126-129.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.